| Primary |
| Epilepsy |
29.5% |
| Product Used For Unknown Indication |
20.3% |
| Migraine |
8.8% |
| Convulsion |
8.6% |
| Drug Use For Unknown Indication |
6.5% |
| Migraine Prophylaxis |
4.5% |
| Drug Exposure During Pregnancy |
3.2% |
| Foetal Exposure During Pregnancy |
2.2% |
| Partial Seizures |
2.1% |
| Headache |
2.0% |
| Status Epilepticus |
1.7% |
| Suicide Attempt |
1.7% |
| Ill-defined Disorder |
1.6% |
| Bipolar Disorder |
1.3% |
| Depression |
1.3% |
| Complex Partial Seizures |
1.1% |
| Schizophrenia |
1.0% |
| Myoclonic Epilepsy |
0.9% |
| Neuralgia |
0.8% |
| Bipolar I Disorder |
0.7% |
|
| Product Substitution Issue |
18.0% |
| Weight Decreased |
7.7% |
| Convulsion |
6.6% |
| Vision Blurred |
6.0% |
| Drug Exposure During Pregnancy |
5.4% |
| Status Epilepticus |
5.3% |
| Visual Impairment |
5.2% |
| Maternal Drugs Affecting Foetus |
5.0% |
| Drug Ineffective |
4.7% |
| Somnolence |
4.4% |
| Completed Suicide |
3.6% |
| Speech Disorder |
3.4% |
| Myopia |
3.3% |
| Vomiting |
3.3% |
| Paraesthesia |
3.2% |
| Suicidal Ideation |
3.2% |
| Suicide Attempt |
3.0% |
| Toxicity To Various Agents |
3.0% |
| Maternal Exposure During Pregnancy |
2.9% |
| Off Label Use |
2.8% |
|
| Secondary |
| Epilepsy |
25.8% |
| Product Used For Unknown Indication |
24.9% |
| Convulsion |
9.5% |
| Drug Use For Unknown Indication |
8.6% |
| Status Epilepticus |
4.7% |
| Migraine |
4.3% |
| Migraine Prophylaxis |
3.2% |
| Infantile Spasms |
2.3% |
| Partial Seizures |
2.3% |
| Bipolar Disorder |
1.9% |
| Ill-defined Disorder |
1.6% |
| Lennox-gastaut Syndrome |
1.6% |
| Depression |
1.5% |
| Schizophrenia |
1.4% |
| Grand Mal Convulsion |
1.3% |
| Anxiety |
1.1% |
| Headache |
1.1% |
| Encephalitis |
1.0% |
| Complex Partial Seizures |
1.0% |
| Psychotic Disorder |
0.9% |
|
| Completed Suicide |
11.2% |
| Status Epilepticus |
8.6% |
| Drug Ineffective |
7.2% |
| Weight Decreased |
6.3% |
| Respiratory Arrest |
5.9% |
| Death |
5.7% |
| Chorea |
5.6% |
| White Blood Cell Count Decreased |
5.3% |
| Somnolence |
4.5% |
| Toxicity To Various Agents |
4.5% |
| Weight Increased |
4.1% |
| Maternal Exposure During Pregnancy |
3.8% |
| Illusion |
3.7% |
| Liver Disorder |
3.7% |
| Vomiting |
3.6% |
| Convulsion |
3.5% |
| Suicide Attempt |
3.4% |
| Hyperammonaemia |
3.3% |
| Maternal Drugs Affecting Foetus |
3.1% |
| Headache |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.1% |
| Epilepsy |
18.8% |
| Drug Use For Unknown Indication |
10.4% |
| Convulsion |
5.7% |
| Migraine |
5.6% |
| Pain |
5.1% |
| Depression |
4.9% |
| Hypertension |
2.8% |
| Multiple Sclerosis |
2.4% |
| Anxiety |
2.3% |
| Headache |
2.3% |
| Rheumatoid Arthritis |
2.2% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Bipolar Disorder |
1.7% |
| Crohn's Disease |
1.7% |
| Status Epilepticus |
1.6% |
| Asthma |
1.6% |
| Schizophrenia |
1.4% |
| Insomnia |
1.3% |
| Sleep Disorder |
1.2% |
|
| Vomiting |
9.7% |
| Weight Increased |
9.1% |
| Convulsion |
7.5% |
| Weight Decreased |
7.1% |
| Drug Ineffective |
6.9% |
| Pulmonary Embolism |
6.0% |
| Nausea |
5.2% |
| Status Epilepticus |
5.2% |
| Epilepsy |
4.4% |
| Acute Psychosis |
4.3% |
| Pain |
4.2% |
| Death |
3.7% |
| Somnolence |
3.7% |
| Tremor |
3.7% |
| Psychotic Disorder |
3.3% |
| Pyrexia |
3.3% |
| White Blood Cell Count Increased |
3.3% |
| Wrong Technique In Drug Usage Process |
3.3% |
| Rash |
3.0% |
| Fatigue |
2.9% |
|
| Interacting |
| Epilepsy |
30.2% |
| Product Used For Unknown Indication |
11.5% |
| Status Epilepticus |
9.0% |
| Convulsion |
7.8% |
| Drug Use For Unknown Indication |
7.8% |
| Bipolar Disorder |
4.7% |
| Cardiovascular Event Prophylaxis |
4.4% |
| Aggression |
3.4% |
| Depression |
2.5% |
| Anxiety |
2.2% |
| Back Pain |
2.2% |
| Blood Cholesterol |
2.2% |
| Hypersensitivity |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Grand Mal Convulsion |
1.9% |
| Agitation |
1.2% |
| Pain |
1.2% |
| Schizophrenia, Paranoid Type |
1.2% |
| Smoking Cessation Therapy |
1.2% |
| Tendonitis |
0.9% |
|
| Drug Interaction |
20.0% |
| Hyperammonaemic Encephalopathy |
18.2% |
| Tremor |
12.7% |
| Alanine Aminotransferase Increased |
3.6% |
| Anxiety Disorder |
3.6% |
| Diplopia |
3.6% |
| Epilepsy |
3.6% |
| Neurotoxicity |
3.6% |
| Psychotic Disorder |
3.6% |
| Rhabdomyolysis |
3.6% |
| Somnolence |
3.6% |
| Suicidal Ideation |
3.6% |
| Visual Field Defect |
3.6% |
| Anticonvulsant Drug Level Decreased |
1.8% |
| Convulsion |
1.8% |
| Death |
1.8% |
| Drug Level Increased |
1.8% |
| Eye Movement Disorder |
1.8% |
| Gait Disturbance |
1.8% |
| Hyperammonaemia |
1.8% |
|
